Skip to main content
OpenTrials
Completed

NCT Number: NCT02614755

An Observational Study of Lumosity in Seniors

The primary objective of this observational study is to determine performance characteristics and usability of Lumosity and the Brain Performance Test in a group of older adult volunteers.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy Volunteers

Age range

55 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Lumos Labs, Inc.

San Francisco, California, 94105, United States

About this study

Approximately 200 prospective users currently will be provided free 6-month premium access Lumosity accounts. Participants will be provided with an account activation code and instructed on how to sign up for Lumosity with their email address. They will be subject to the Lumosity Terms of Service and follow the typical user experience. Upon creating an account, users would be asked to complete a short demographic survey that includes questions on gender, education, occupation, years since retirement, health, computer familiarity, and perceptions of brain training.

Those who sign up will have immediate access to the Lumosity training system and the entire suite of Lumosity games. In addition, they will be invited, via email, to take the Brain Performance Test one week after the initial sign-up and then again 12 weeks later. Approximately every 8 weeks, users will be asked to complete a short questionnaire about their experience with Lumosity. This questionnaire will be accessed via email. Participants will be asked to train 5 days a week for 20-30 minutes per day, but are free to play as much or a little as they choose. Community associates at the sites will be encouraged to host group training sessions, giving the seniors a chance to gather and complete their training together, share their experiences, and get any help they may need. In addition, sites will have the option of hosting 1-2 focus groups with participants and researchers from Lumos Labs. The focus groups will be an opportunity to give and receive direct feedback about Lumosity, and get any questions answered by the researchers.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Participants must meet the following criteria:

  • 55 years of age or older
  • English-speaker
  • Cognitively stable (i.e., without a known diagnosis that may affect cognitive abilities)
  • Regular access to and ability to use a computer or mobile device with Internet connectivity.

Exclusion criteria

  • Under 55 years of age
  • Have a current diagnosed cognitive or neuropsychological condition
  • Are taking medication that may impede cognitive functioning
  • Anticipate a dosage change in medication that may affect cognitive functioning during the course of the study (24 weeks)
  • Have other conditions or problems that may preclude regular computer usage

Treatment and study plan

Primary outcomes

  1. Usability - as measured by self-report feedback surveys

    Time frame: Change from Baseline - collected at baseline, 3 months and 6 months

    Using self-report surveys administered to participants at baseline, 3 months and 6 months, investigators will calculate a usability score of Lumosity.

Secondary outcomes

  1. User Engagement - as measured by number of unique days played

    Time frame: 6 months

    Calculating the number of unique days played will allow us to estimate the engagement level of study participants.

  2. Change from baseline on the Lumosity Performance Index (LPI)

    Time frame: Change from Baseline - collected at baseline and 6 months

    To evaluate the Lumosity Performance Index (LPI) results in a group of seniors

  3. Change from baseline on the Brain Performance Test (BPT)

    Time frame: Change from Baseline - collected at baseline, 3 months and 6 months

    To evaluate the Brain Performance Test (BPT) results in a group of seniors

Sponsors and collaborators

Lead sponsor

Lumos Labs, Inc.

Industry

Registry information

Important dates

Study start
2015
Primary completion
2017
Study completion
2017
First posted
Nov 25, 2015
Registry last updated
May 25, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.